SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-15-009644
Filing Date
2015-12-10
Accepted
2015-12-10 19:27:15
Documents
1
Period of Report
2015-12-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5375
  Complete submission text file 0000899243-15-009644.txt   6720
Mailing Address 508 WRANGLER DRIVE, SUITE 100 COPPELL TX 75019
Business Address 508 WRANGLER DRIVE, SUITE 100 COPPELL TX 75019 650-458-4100
ZS Pharma, Inc. (Issuer) CIK: 0001459266 (see all company filings)

IRS No.: 263305698 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ZS PHARMA, INC. 508 WRANGLER DRIVE, SUITE 100 COPPELL TX 75019
Business Address
Tomasi Adam (Reporting) CIK: 0001637219 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36489 | Film No.: 151281919